CBL and myelodysplastic syndrome: Along these lines, recent work evaluating the role of gene mutations on the prognosis of myelodysplastic syndromes demonstrated that patients with mutations in KRAS or NF1 show worse OS than patients with NRAS or CBL mutations49.